Doctrina Raises €1,020,000 of New Capital

Doctrina, a start-up company transforming the traditional transfer of knowledge between pharmaceutical companies and pharmacies, has raised a total of €1,020,000 in series A funding. The investment will enable Doctrina to execute its growth plans and scale its solution to new markets.

"We are excited to receive the new capital from our investors," says Tomaž Erjavec, founder and managing partner of Doctrina. "Our goal is to make Doctrina an indispensable part of pharmacists' workdays with the mission to optimize the transfer of knowledge and patient safety."

Doctrina helps pharmacists to access knowledge about new pharmaceutical products and other professional novelties on one independent platform. Due to the amount of products each pharmacy offers, it's impossible for the employees of the pharmacies to keep track of all changes and innovations. Based on the fact that 87% of healthcare professionals conclude contact with a pharmaceutical sales rep in less than two minutes and that sales reps spend 50% of their working time in their cars, Doctrina has developed a signature technology that enables pharmaceutical companies to achieve greater reach, faster knowledge delivery with real-time feedback, and more efficient two-way communication. The method used to further train the pharmacists has been developed with the latest e-learning trends and is available in a video micro-learning format. This helps pharmacists and pharmaceutical technicians to access knowledge about products and all content in one place, anytime and on any device.

A substantial portion of investment will be used to execute the company's growth plans, which are focused on Poland and the UK, as well as some other smaller markets, but will also focus on further product development, and the expansion of the international team.

"Our platform is already used by 55,000 pharmacists from Poland, Russia, Slovenia, Romania and Croatia. The plan is to now bring our technology to other countries in Europe and enable pharmaceutical companies and pharmacists to increase the flow of effective knowledge transfer. We are also focusing on finding digital health enthusiasts to join our international team working on multiple markets." commented Jure Pučko, CEO and founder of Doctrina. "Our vision is to make Doctrina an indispensable daily source of product news and other professional information."

For further information, please visit:
https://en.doctrina.biz

About Doctrina
Doctrina is an online platform that allows pharmaceutical companies to further train pharmacy employees through webinars. It assists sales representative visits with greater and faster reach, lower costs, and accurate analytics. The platform is used daily by over 55,000 pharmacists from Slovenia, Romania, Poland, Russia and Croatia.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...